Sinusoidal obstruction syndrome risk factors: Difference between revisions
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of Sinusoidal obstruction syndrome are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4] | |||
==Risk Factors== | ==Risk Factors== | ||
Revision as of 02:37, 1 February 2018
|
Sinusoidal obstruction syndrome Microchapters |
|
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sinusoidal obstruction syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome risk factors |
|
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
|
Risk calculators and risk factors for Sinusoidal obstruction syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Common risk factors in the development of Sinusoidal obstruction syndrome are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]
Risk Factors
Common risk factors for sinusoidal obstruction syndrome are:[1]
- Stem cell transplantation
- Preexisting liver dysfunction (elevated transaminases, fibrosis or cirrhosis, low pseudocholinesterase level or low albumin level pretransplantation)
- Presence of hepatic metastases
- Advanced age
- Prior radiation treatment of the liver
- High-dose conditioning regimens
- Allogeneic transplantation (compared with autologous transplantation)
References
- ↑ Kumar S, DeLeve LD, Kamath PS, Tefferi A (2003). "Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation". Mayo Clin Proc. 78 (5): 589–98. doi:10.4065/78.5.589. PMID 12744547.